The Immune Response Corporation Report issue

For profit Phase 2 Phase 3
Founded: Carlsbad CA United States (1986)
Status: Defunct (2009)

Organization Overview

First Clinical Trial
1999
NCT00002172
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Immune Response BioPharma | Immune Response BioPharma, Inc. | Immune Response BioPharma, Inc. Chief R&D Officer